A recent study reported six unrelated patients carrying heterozygous de novo variants in POLR3B manifested ataxia, developmental delay, spasticity and demyelinating neuropathy, which differed from previously reported phenotypes of POLR3B-related hypomyelinating leukodystrophy [3]. This evidence concerns the gene POLR3B and Ataxia.